Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | AVIR | AUTL | ||
| Company | Cellular Biomedicine | Atea Pharmaceuticals Inc | Autolus Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.74 | 4.75 | 1.4200 | ||
| High | 19.75 | 4.81 | 1.4600 | ||
| Low | 19.73 | 4.67 | 1.4140 | ||
| Latest | 19.75 | 4.79 | 1.4450 | ||
| Change | unch | -0.02 | +0.0050 | ||
| % Change | unch | -0.42% | +0.35% | ||
| Volume | 171,900 | 63,115 | 282,139 | ||
| 20-Day Average Volume | 197,580 | 345,443 | 1,119,551 | ||
| Previous Close | 19.75 | 4.81 | 1.4400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 4.77 | 1.5475 | ||
| 20-Day Raw Stochastic | 99.77% | 66.67% | 20.55% | ||
| 20-Day Relative Strength | 67.50 | 51.47 | 45.04 | ||
| Weighted Alpha | +21.75 | +27.73 | -29.28 | ||
| Today's Opinion | 100% Buy | 40% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 8% Sell | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | +1.59% since 07/16/26 | -0.34% since 07/16/26 | ||
| Low | 19.68 on 02/12/21 | 4.64 on 07/17/26 | 1.3800 on 07/21/26 | ||
| High | 19.75 on 02/18/21 | 4.97 on 07/20/26 | 1.4900 on 07/22/26 | ||
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | +6.92% since 06/23/26 | -12.35% since 06/23/26 | ||
| Low | 17.60 on 01/28/21 | 4.30 on 06/25/26 | 1.3800 on 07/21/26 | ||
| High | 19.75 on 02/18/21 | 5.03 on 07/02/26 | 1.7450 on 07/08/26 | ||
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | -13.22% since 04/23/26 | -4.90% since 04/23/26 | ||
| Low | 17.60 on 01/28/21 | 4.04 on 05/18/26 | 1.3800 on 07/21/26 | ||
| High | 19.75 on 02/18/21 | 5.83 on 05/05/26 | 1.9500 on 05/18/26 | ||
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | +16.26% since 01/23/26 | -0.34% since 01/23/26 | ||
| Low | 16.98 on 11/06/20 | 3.75 on 01/28/26 | 1.1750 on 03/27/26 | ||
| High | 19.75 on 02/18/21 | 6.45 on 03/10/26 | 1.9500 on 05/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 384,930 | 383,265 | ||
| Shares Outstanding, K | 19,478 | 80,027 | 266,156 | ||
| Annual Sales | 340,000 | 0 | 75,390,000 | ||
| Annual Net Income | -49,980,000 | -158,350,000 | -287,530,000 | ||
| Last Quarter Sales | 30,000 | 0 | 26,220,000 | ||
| Last Quarter Net Income | -17,040,000 | -45,440,000 | -71,600,000 | ||
| 60-Month Beta | 1.17 | 0.31 | 2.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.57 on 05/12/26 | -0.27 on 05/14/26 | ||
| Earnings Date | 02/26/21 | 08/06/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||